We can therefore assert that in patients affected by lung cancer, there is important reorganization in the immune system, particularly an increase in platelets and neutrophils; contrarily, lymphocytes tend to decrease with a subversion of the different inflammatory parameters, such as NLR, PLR, HALP, SII, and ALI. Here, NAT10 is linked to lung carcinoma.